Korean Diet Efficacy Clinical Trial

May 13, 2010 updated by: University of Sydney

A 13 Week Study to Examine the Effectiveness of the Korean Diet on Weight, Blood Pressure, Metabolic Parameters and Disease Control in an Australian Overweight and Obese Population.

To determine:

  1. the acceptability of a Korean diet to an Australian overweight and obese population
  2. which Korean recipes are easily prepared
  3. the effect of a Korean diet on weight, blood pressure, and metabolic complications of obesity in this population.

Study Overview

Detailed Description

The primary endpoint (Korean diet acceptability) will be assessed by reliability tested questionnaire, dietary compliance, and quantities of food returned over the 12 weeks.

Analysis of differences in weight loss will be based on all participants with a baseline and a 12-week weight assessment. In order to investigate the impact of missing data, all subjects will be analysed using last weight observation carried forward and baseline weight carried forward.

Other secondary endpoints will determine the effect of the Korean diet on blood pressure, metabolic parameters and chronic metabolic disease control in the Australian population.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • Sydney, New South Wales, Australia, 2006
        • The University of Sydney

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Residents of metropolitan Sydney
  • Aged 18-65 years
  • BMI 25-45kg/m2

Exclusion Criteria:

  • Diabetes treated with oral medications or insulin
  • Unstable angina or recent onset of cardiovascular disease
  • Serious hepatic or renal disease
  • serum transaminases (ALT or AST) > 2.5 times upper limit of normal
  • serum creatinine > 1.5 times upper limit of normal or urinary microalbumin >40 mg/L or eGFR < 60ml/min/1.73m²
  • Alcohol or illicit drug abuse
  • Pregnant, breastfeeding, or planning pregnancy during the study
  • Serious gastrointestinal disease (inflammatory bowel disease, active peptic ulcer, recent helicobacter pylori treatment)
  • Treatment for an eating disorder, weight loss medications and other drugs that affect body weight e.g. some anti-psychotics, anti-depressants, or corticosteroids
  • Hypothyroidism defined by elevated thyroid stimulating hormone (TSH) and low free thyroxine (fT4), or current hyperthyroidism under treatment
  • Participation in another weight loss clinical trial within past 3 months
  • Individuals who have lost >10% weight within past 3 months
  • Vegetarian eating practices
  • Inability to cook or lack of facilities for home cooking
  • Inability to read and write English
  • Subjects who frequently change smoking habits or who have stopped smoking within 6 months prior to screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Korean Diet
Provision of 2 Korean meals per day, 6 days per week
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Korean diet group will pick up lunch and evening meals Monday-Friday. Raw ingredients and cooking instructions will also be provided on friday for saturday meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.
Active Comparator: Western Diet
Lifestyle counseling, dietary advice, grocery vouchers
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Western diet group will be provided with a Western recipe cookbook and food vouchers (weekly) to purchase the necessary ingredients for the Western meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. To investigate the acceptability of a Korean diet in overweight and obese Australians.
Time Frame: 13 weeks
This will be determined at baseline and 4 week timepoints throughout the study by participants completing a Food Acceptability Questionnaire (FAQ). The FAQ addresses 10 components of food acceptability along a 7-point Likeart scale. The FAQ is a recognised instrument for testing food acceptability.
13 weeks
2. To examine the differences in weight loss between the Korean diet intervention and the Western diet intervention in overweight and obese Australians.
Time Frame: 13 weeks
This will be determined by assessing differences at baseline and 12 weeks for weight, BMI and percent BMI change.
13 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
To investigate changes in a number of indicators of metabolic disease in both groups - including anthropometry, Blood Glucose Levels, insulin sensitivity, lipid profiles, liver function, hormone function and inflammatory markers.
Time Frame: 13 weeks
13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ian D Caterson, AM, MBBS, BSc(Med), PhD, FRACP, University of Sydney

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Anticipated)

June 1, 2010

Study Completion (Anticipated)

April 1, 2011

Study Registration Dates

First Submitted

April 22, 2010

First Submitted That Met QC Criteria

May 13, 2010

First Posted (Estimate)

May 14, 2010

Study Record Updates

Last Update Posted (Estimate)

May 14, 2010

Last Update Submitted That Met QC Criteria

May 13, 2010

Last Verified

April 1, 2010

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 11-2009/12124

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Provision of 2 Korean meals per day 6 days per week

Subscribe